Abbott Diagnostics provides molecular testing systems and assays designed to support personalized healthcare. Its offerings serve infectious disease, oncology and genetics, helping laboratories generate information that can guide important health decisions. The portfolio includes Alinity m, a fully integrated, automated, high-throughput molecular diagnostics analyzer, paired with assays intended to bring flexibility and efficiency to laboratory workflows.

For infectious disease testing, Abbott’s solutions support earlier diagnosis, therapy selection, personalized care and ongoing disease monitoring. Its Alinity m HR HPV assay includes a self-collection option intended to expand access to cervical health screening. Abbott also offers the simpli-COLLECT STI Test system, which is FDA-cleared for self-collection in a home setting, and a simpli-COLLECT HPV collection kit, described as FDA-approved for use in a clinical setting.

Through its molecular products and laboratory solutions, Abbott aims to advance testing and help healthcare professionals make informed decisions. The company provides product information, technical support and safety data resources for customers using its diagnostic systems and assays.